Edition:
United Kingdom

Heska Corp (HSKA.OQ)

HSKA.OQ on NASDAQ Stock Exchange Capital Market

79.80USD
19 Jan 2018
Change (% chg)

$-0.24 (-0.30%)
Prev Close
$80.04
Open
$79.88
Day's High
$81.09
Day's Low
$79.26
Volume
15,436
Avg. Vol
27,067
52-wk High
$114.63
52-wk Low
$75.63

Chart for

About

Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging... (more)

Overall

Beta: 0.82
Market Cap(Mil.): $694.57
Shares Outstanding(Mil.): 7.23
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.28 16.58
EPS (TTM): -- -- --
ROI: -- 13.90 10.60
ROE: -- 16.71 14.19

BRIEF-Heska reports Q3 earnings per share $0.40

* Q3 earnings per share view $0.41 -- Thomson Reuters I/B/E/S

02 Nov 2017

BRIEF-Heska announces 7-year agreement with PetVetCare Centers

* Heska announces 7-year agreement with PetVetCare Centers Source text for Eikon: Further company coverage:

01 Nov 2017

BRIEF-Heska reports Q2 earnings per share $0.44

* Q2 earnings per share view $0.36 -- Thomson Reuters I/B/E/S

31 Jul 2017

BRIEF-Heska adds growth capital with $30 mln credit agreement with JPMorgan Chase

* Says credit agreement matures in July 2020 and replaces company's existing $15 million asset based line of credit

28 Jul 2017

Competitors

  Price Chg
Pfizer Inc. (PFE.N) $36.94 -0.05
Novartis AG (NOVN.S) CHF83.38 +0.48
Merck & Co., Inc. (MRK.N) $61.28 +0.15
Bayer AG (BAYGn.DE) €104.08 +0.60
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €72.95 +0.58
Eli Lilly and Co (LLY.N) $85.49 -0.33
IDEXX Laboratories, Inc. (IDXX.OQ) $180.63 +1.63
Virbac SA (VIRB.PA) €119.00 -0.20
Vetoquinol SA (VETO.PA) €62.00 -0.40

Earnings vs. Estimates